Summary
A 60-year-old woman with gastric cancer had undergone partial gastrectomy in September 1989. Pathological examination revealed a poorly differentiated adenocarcinoma of pT3pN3pM0 (not resected for cure), stage IV. Postoperative adjuvant therapy comprised 1-(tetrahydro-2-furanyl)-5-fluorouracil plus uracil and OK-432. On 11 August 1990, two forefinger-tip-sized tumors were palpated beneath the operation scar. They increase in size, the superior tumor reaching 4×3 cm, the inferior tumor 5×3 cm on 5 September. Then, on 17 September, the inferior tumor was resected but the superior tumor remained; the histological type was poorly differentiated adenocarcinoma. After the operation, from 20 September, she was given 4 mg irsogladine maleate orally every day. On 8 October, there was no increase in the size of the superior tumor. By 29 October, the superior tumor had disappeared and no further tumor appeared thereafter; the patient showed no sign of relapse.
Abbreviations
- FT:
-
1-(tetrahydro-2-furanyl)-5-fluorouracil
References
Kunitomo K, Kuwashima, T, Korematsu H (1981) Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 9:72
Oyamada M, Yamasaki M (1989) Functions of gap-junction. Jikken Igaku (exp Med) 7:1181
Stanbridge EJ, Der C, Doersen J (1982) Human cell hybrid: analysis of transformation and tumorigenicity. Science 215:252
Ueda F, Aratani S, Kimura K (1984) Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals. Arzneimittelforschung (Drug Res) 34:474
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hosokawa, T., Otani, Y., Ogawa, K. et al. Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. J Cancer Res Clin Oncol 118, 565–566 (1992). https://doi.org/10.1007/BF01211796
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01211796